 |
|
|
| |
Safety and Analytical Treatment Interruption Outcomes in a Clinical Trial of 2 Broadly Neutralizing Antibodies Plus Vesatolimod in Early-Treated South African Women With Clade C HIV-1
|
| |
| |
20th European AIDS Conference; October 15-18, 2025; Paris, France
Daina Lim1, Olivia Fu1, Xiaopeng Liu1, Megha Mehrotra1, Devi SenGupta1, Thumbi Ndung'u2, Lucio Gama3, Vanessa Pillay4, Vaneshree Govender5, Villeshni Asari6, Krista Dong7
|
| |
|
|
|
|
|
